Attached files
| file | filename |
|---|---|
| EX-31.1 - TOP FLIGHT GAMEBIRDS, INC. | v229174_ex31-1.htm |
| EX-31.2 - TOP FLIGHT GAMEBIRDS, INC. | v229174_ex31-2.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20-549
FORM 10-Q/A
Amendment No. 2
(Mark One)
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended March 31, 2011
or
|
o
|
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT
|
For the transition period from ______________ to _____________
Commission file number: 333-152286
GLOBAL PHARM HOLDINGS GROUP, INC.
(Exact name of registrant as specified in its charter)
|
Delaware
|
20-8767223
|
|
|
(State or other jurisdiction of incorporation or
|
(I.R.S. Employer Identification No.)
|
|
|
organization)
|
||
|
25/F New World Center, No. 6009 Yitian Road, Futian District,
|
518026
|
|
|
Shenzhen,
|
(Zip Code)
|
|
|
People’s Republic of China
|
||
|
(Address of principal executive offices)
|
86-755-83230226
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes o No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer o
|
Accelerated filer o
|
|
Non-accelerated filer o
|
Smaller reporting company x
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o No x
APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13, or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes o No o
APPLICABLE ONLY TO CORPORATE ISSUERS
Indicate the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date:
As of July 15, 2011, there are 26,000,000 of $0.001 par value common stock issued and outstanding.
Item 6. Exhibits
Copies of the following documents are included as exhibits to this report pursuant to Item 601 of Regulation S-K.
|
Exhibit No.
|
Title of Document
|
|
|
31.1
|
Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
31.2
|
Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
SIGNATURES
In accordance with the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
GLOBAL PHARM HOLDINGS GROUP, INC.
|
|||
|
Date: July 21, 2011
|
/s/ Yunlu Yin
|
||
|
Yunlu Yin
|
|||
|
Chief Executive Officer and President
|
|||
|
(Principal Executive Officer)
|
|||
|
Date: July 21, 2011
|
/s/ An Fu
|
||
|
An Fu
|
|||
|
Chief Financial Officer
|
|||
|
(Principal Financial Officer)
|